STAMFORD, Conn., Nov. 23, 2015 /PRNewswire/ -- The Lockwood Group was recently presented with the Award for Excellence by The Rx Club for their work on an interactive publications guide developed for AstraZeneca. Healthcare Agencies were honored for their achievements in utilizing new technology to design innovative integrated campaigns to bring their clients' creative ideas to life.
Now in the 29th year, the Rx Club Show was created to recognize and honor the creative aspects of healthcare advertising and promotion. The competition was founded in 1986 by Ina and Carveth Kramer. For more information about the Rx Club Show, visit: www.therxclub.com.
Lockwood was one of eighteen agencies selected for an award amongst hundreds who submitted work from around the world. A growing force in the medical communications space, with nearly 100 employees within the firm, Lockwood was honored to be recognized amongst large global firms such as Sudler & Hennessey, Ogilvy and McCann. View the winning project here: http://www.therxclub.com/rxclub/rx2015/rxpopup.php?e_id=245
Lockwood collaborates with clients in the pharmaceutical, biotech, and medical device industries to identify effective, holistic, science-based strategies to address their objectives through medical communications. Matthew Schecter, President and CEO said, "The award is a source of great pride to our agency, and shows our ability to deliver innovative work to our clients that also provides the highest quality scientific content."
Founded in 2007 and headquartered in Stamford, Connecticut, Lockwood is a mid-sized agency utilizing a 21st century business model to help clients communicate clinical and therapeutic advances to every variety of medical expert, healthcare practitioner, and decision maker. For the ultimate benefit of patients, Lockwood helps clients advance their objectives in a world of new regulations, business models, payment approaches, technologies, roles, and work practices. Lockwood teams are organized around the specific needs of each client. With experience in all major therapeutic areas and many rare diseases, along with highly specialized knowledge in biologics, devices, and diagnostics, Lockwood can quickly deploy the right scientific, business, and communications experts to address the challenges at hand.
SOURCE The Lockwood Group